![]() |
市場調査レポート
商品コード
1451626
間欠式カテーテル市場レポート:製品、適応症、カテゴリー、エンドユーザー、地域別、2024-2032Intermittent Catheters Market Report by Product, Indication (Urinary Incontinence, Surgery, Spinal Cord Injury, and Others), Category, End User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
間欠式カテーテル市場レポート:製品、適応症、カテゴリー、エンドユーザー、地域別、2024-2032 |
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 146 Pages
納期: 2~3営業日
|
間欠式カテーテルの世界市場規模は2023年に27億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに47億米ドルに達し、2024年から2032年の間に6.02%の成長率(CAGR)を示すと予測しています。
間欠式カテーテル療法は、膀胱から尿を排出するためにカテーテルを挿入・抜去する方法です。特発性または神経原性膀胱留置過活動(NDO)機能障害、炎症、神経学的状態、薬理学的薬剤、物理的な膀胱閉塞が原因で膀胱の排出が不完全な患者にとって、効果的な膀胱管理戦略です。膀胱の膨張や尿路感染症(UTI)を予防しながら、使いやすく便利です。これに加えて、漏出、閉塞、膀胱痙攣を回避できるため、間欠式カテーテルの需要は世界中で増加しています。
現在、世界中で尿路感染症(UTI)や尿道の閉塞に悩む患者が増加しています。これは、尿路や生殖器官における腫瘍の増加とともに、市場を牽引する重要な要因の1つとなっています。さらに、膀胱炎、前立腺肥大症、腎臓結石などの泌尿器疾患の有病率が大衆の間で上昇していることも、業界の投資家に有利な成長機会を提供しています。このほか、脊髄損傷、多発性硬化症、認知症など、さまざまな病状における間欠式カテーテルの需要が増加しています。これは、急成長するヘルスケア産業と相まって、市場の成長に寄与しています。さらに、主な市場参入企業は研究開発(R&D)活動に積極的に投資しており、2次感染からの保護を強化するために温度モニタリング機能付き被覆尿道カテーテルを導入しています。また、ヘルスケア施設を訪れて治療を受けることができない患者向けに、オンラインカウンセリングやガイダンスを提供するプラットフォームを立ち上げています。これとは別に、親水性抗菌間欠式カテーテルなどの新規カテーテルに対する需要の高まりが市場の成長を後押ししています。
The global intermittent catheters market size reached US$ 2.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 4.7 Billion by 2032, exhibiting a growth rate (CAGR) of 6.02% during 2024-2032.
Intermittent catheterization is a procedure of inserting and removing a catheter to drain urine from a bladder. It is an effective bladder management strategy for patients with incomplete bladder emptying due to idiopathic or neurogenic detrusor overactivity (NDO) dysfunction, inflammation, neurological conditions, pharmacological agents, and physical bladder obstruction. It is easy to use and convenient while preventing a distended bladder or a urinary tract infection (UTI). Besides this, as it avoids leaking, blockage, and bladder spasms, the demand for intermittent catheters are increasing across the globe.
At present, there is a rise in the number of patients suffering from urinary tract infections (UTIs) and blockages in the urethra around the world. This, along with the growing incidences of tumors in the urinary tract or reproductive organs, represents one of the key factors driving the market. Moreover, the rising prevalence of urological disorders, such as cystitis, benign prostatic hyperplasia, and kidney stones, among the masses is offering lucrative growth opportunities to industry investors. Besides this, there is an increase in the demand for intermittent catheters in various medical conditions, such as spinal cord injury, multiple sclerosis, or dementia. This, coupled with the burgeoning healthcare industry, is contributing to the growth of the market. In addition, key market players are extensively investing in research and development (R&D) activities to introduce coated urine catheters with temperature monitoring for enhanced protection against secondary infections. They are also launching platforms for providing online counseling and guidance to patients who cannot visit healthcare facilities for treatment. Apart from this, the escalating demand for novel catheters, such as hydrophilic antimicrobial intermittent catheters, is bolstering the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global intermittent catheters market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, indication, category and end user.
Uncoated Intermittent Catheter
Coated Intermittent Catheter
Antimicrobial
Hydrophilic
Others
Urinary Incontinence
Surgery (Major Surgery)
Spinal Cord Injury
Others
Male Length Catheter
Kids Length Catheter
Female Length Catheter
Hospitals
Medical Research Centers
Ambulatory Surgical Centers
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being B. Braun Melsungen AG, Becton Dickinson and Company, Coloplast A/S, Cure Medical LLC (Convatec Group plc), Hollister Incorporated, Hunter Urology, Medical Technologies of Georgia Inc., Pennine Healthcare Ltd., Teleflex Inc and Wellspect Limited (Dentsply Sirona).